These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10088127)

  • 1. Why are dendritic cells central to cancer immunotherapy?
    Colaco CA
    Mol Med Today; 1999 Jan; 5(1):14-7. PubMed ID: 10088127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel perspectives on dendritic cell-based immunotherapy of cancer.
    Bonaccorsi I; Pezzino G; Morandi B; Ferlazzo G
    Immunol Lett; 2013; 155(1-2):6-10. PubMed ID: 24076312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell vaccines for cancer immunotherapy.
    Timmerman JM; Levy R
    Annu Rev Med; 1999; 50():507-29. PubMed ID: 10073291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic/tumor fusion cell-based vaccination against cancer.
    Koido S; Hara E; Homma S; Fujise K; Gong J; Tajiri H
    Arch Immunol Ther Exp (Warsz); 2007; 55(5):281-7. PubMed ID: 18219758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunotherapy with dendritic cells in cancer: current status.
    Nencioni A; Brossart P
    Stem Cells; 2004; 22(4):501-13. PubMed ID: 15277696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
    Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
    J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic modification of dendritic cells and its application for cancer immunotherapy.
    Nishioka Y; Hua W; Nishimura N; Sone S
    J Med Invest; 2002 Feb; 49(1-2):7-17. PubMed ID: 11901764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell activation kinetics and cancer immunotherapy.
    Bellone M; Camporeale A; Boni A
    J Immunol; 2004 Mar; 172(5):2727-8. PubMed ID: 14978067
    [No Abstract]   [Full Text] [Related]  

  • 11. Dendritic cells in vaccination therapies of human malignant disease.
    Reichardt VL; Brossart P; Kanz L
    Blood Rev; 2004 Dec; 18(4):235-43. PubMed ID: 15501552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T; Tang C; Xu S; Moyana T; Xiang J
    Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine for improvement of dendritic cell-based cancer immunotherapy.
    Hashemi V; Farhadi S; Ghasemi Chaleshtari M; Seashore-Ludlow B; Masjedi A; Hojjat-Farsangi M; Namdar A; Ajjoolabady A; Mohammadi H; Ghalamfarsa G; Jadidi-Niaragh F
    Int Immunopharmacol; 2020 Jun; 83():106446. PubMed ID: 32244048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-based therapy as a multidisciplinary approach to cancer treatment: present limitations and future scopes.
    Fazle Akbar SM; Abe M; Yoshida O; Murakami H; Onji M
    Curr Med Chem; 2006; 13(26):3113-9. PubMed ID: 17168700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with dendritic cells for cancer.
    Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
    Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-based immunotherapy: a basic review and recent advances.
    Constantino J; Gomes C; Falcão A; Neves BM; Cruz MT
    Immunol Res; 2017 Aug; 65(4):798-810. PubMed ID: 28660480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy against tumor with dendritic cell sensitized by necrotic tumor tissue after microwave coagulation therapy].
    Yao LC; Yang RJ
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2552-6. PubMed ID: 18067832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells as adjuvants for immune-mediated resistance to tumors.
    Schuler G; Steinman RM
    J Exp Med; 1997 Oct; 186(8):1183-7. PubMed ID: 9379142
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficient induction of anti-tumor immune response in esophageal squamous cell carcinoma via dendritic cells expressing MAGE-A3 and CALR antigens.
    Liu X; Song N; Liu Y; Liu Y; Li J; Ding J; Tong Z
    Cell Immunol; 2015 Jun; 295(2):77-82. PubMed ID: 25863743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.